The recurring instances of infectious disease outbreaks, coupled with complications such as
comorbidity challenges and antibiotic resistance, consistently underscore the limitations …

Nucleic acid amplification technologies (NAATs) are high-performance tools for rapidly and
accurately detecting infectious agents. They are widely used in high-income countries to …

Diagnostic tests were heralded as crucial during the Coronavirus disease (COVID-19)
pandemic with most of the key methods using bioanalytical approaches that detected larger …

The ongoing pandemic and increasing frequency of infectious disease outbreaks due to
climate change, urbanization, and global human migration have put great focus on nucleic …

Introduction: Rapidity, simplicity, and portability are highly desirable characteristics of tests
and devices designed for performing diagnostics at the point of care (POC), either near …

The COVID-19 pandemic has put the spotlight on the urgent need for integrated nucleic acid
tests (NATs) for infectious diseases, especially those that can be used near patient (“point-of …

Emerging molecular technologies to diagnose infectious diseases at the point at which care
is delivered have the potential to save many lives in developing countries where access to …

Recent advances in bioengineering have enabled development of sensitive and specific
diagnostic tests that detect and quantify cells, proteins, and nucleic acids. However, the …

Point-of-care diagnosis based on nucleic acid testing aims to incorporate all the analytical
steps, from sample preparation to nucleic acid amplification and detection, in a single …

Infectious agents, both standard and emerging or engineered, might initiate outbreaks with
global impact and/or existential-level threat potential. Such agents might infect human …